Introduction {#sec1-1}
============

Cancers are the top leading cause of death. According to estimates of The World Health Organization (WHO), approximately 8.2 million cancer deaths occurred in 2014 and mortality mainly occurred in developing countries. Of these, 3.4 million are male and female 3.3 million. Almost 70 % of all cancers was seen in underdeveloped and developing countries (Siegel et al., 2015). At present, it is well established that BC is the most commonly diagnosed invasive cancer and the leading cause of cancer death among women worldwide including in Thailand (Siegel et al., 2015; National Cancer Control Committee, 2013; Bureau of Policy and Strategies, 2011; Bureau of Policy and Strategies, 2015). Causes of being BC are likely to be multifactorial. Some studies found that OC use is one of the risk factors of BC (Soroush et al., 2016; Rosenberg et al., 2009). The association between OC use and BC risk has been examined in numerous studies, mainly in western countries. In Thailand, there are quite very few studies of this association among premenopausal women. The present study was carried out to assess the association between OC use and BC occurrence among TPW.

Materials and Methods {#sec1-2}
=====================

Study Design, Sample Size and Sampling Technique {#sec2-1}
------------------------------------------------

A hospital based case-control study (1:1) was performed at the National Cancer Institute in Bangkok during November 2013 -December 2014 to determine the effect of OC use and BC risk among TPW. A total of 257 BC cases and 257 controls were included in the study. The cases were newly diagnosed with breast cancer by pathologists. The controls were healthy TPW who had annual health check-up. Cases and controls were matched (1:1) by age (±5 years), residential area and duration of attending. Of the 514 women were both premenopausal and aged \<45 years at the time of study. Cases and controls used the same questionnaire to obtain data collection.

The sample size was calculated by the formula (Lwanga and Lemeshows, 1991). Where Po = proportion of exposure in controls = 0.32 (Umpan, 2004); P1 = proportion of exposure in cases = 0.68 (Umpan, 2004); Zα/2 = 1.96 at α = 0.05; Zβ = 0.84 at β = 0.20; and P = 0.5. The calculated sample size in each group was at least 256.

Tool and Measurements {#sec2-2}
---------------------

Data collection was obtained by interviewing the study subjects by researcher and trained research assistants. The questionnaire comprised socio-demographic factors, health risk behaviors, reproductive factors, obesity and cancer status. While BC information was collected by laboratory and pathological results, namely, TNM classification, stage of disease, hormone receptor test, and date of diagnosis with BC.

Variable definitions {#sec2-3}
--------------------

Premenopausal women were defined as those still having menstrual cycles at the time of study.

Ethical Considerations {#sec2-4}
----------------------

The study was reviewed and approved by the Ethics Committee for research of National Cancer Institute, Ministry of Public Health (148/2556) and the Ethics Committee for Research in Human Subjects of the Faculty of Public Health, Mahidol University (Ref No. MuPH 2014-090) and agreed with the Helsinki declaration. All participants participated in this study are on a voluntary basis. Informed consent to participate in the study was obtained from participants after providing sufficient information. Information was collected by a self-administered questionnaire with the help and supervision of research assistants. Confidentiality was well kept throughout the study using anonymous technique (respondents were identified by code numbers to ensure confidentiality and the results were analyzed as a whole).

Statistical Analyses {#sec2-5}
--------------------

The data were analyzed with SPSS version 18 (IBM, NY, USA). Categorical variables were given as a frequency and percentage, crude odds ratio, 95 % Confidence Interval (CI) of OR and p-value. The numerical variables were expressed as mean, minimum and maximum, and standard deviation (SD). Univariate analysis was performed using the chi-square test to differentiate proportional exposures between BC patents and controls for categorical variables. Adjusted odds ratio and the 95 % CI of OR were calculated from multiple unconditional logistic regression to examine associations between BC occurrence and BMI, adjusted for potential confounding factors of reproductive factors and health risk behaviors. A p-value of \< 0.05 was considered to be statistically significant.

Results {#sec1-3}
=======

Demographic Characteristics of Cases and Controls {#sec2-6}
-------------------------------------------------

A total of 514 TPW participated in the case-control study (1:1). The average age of subjects was 39 years. [Table 1](#T1){ref-type="table"} outlines the socio-demographic characteristics of them. To summarize majority of them were aged 40-44 years (59.9%, 61.1%), married (61.8%, 60.7%), higher education (39.7%, 51.4%), buddhism (96.5%, 96.1%), living in central region (68.5%), office employee (35.8%, 33.8%), and had monthly family income of 15,000-30,000 baht (53.7%, 48.2%). There was no significant difference regarding demographics among cases and controls (p\>0.05).

###### 

General Characteristics of Cases and Controls

  Characteristics                Cases No.              \%     Controls No.            \%     p value^[a](#t1f1){ref-type="table-fn"}^
  ------------------------------ ---------------------- ------ ----------------------- ------ ------------------------------------------
  Age gr. (yrs)                                                                               0.981
    ≤ 29                         10                     3.9    11                      4.3    
    30-34                        30                     11.7   28                      10.9   
    35-39                        63                     24.5   61                      23.7   
    40-44                        154                    59.9   157                     61.1   
  Mean (SD)                      39.20 (4.39)                  39.30 (4.41)                   
  Min-Max                        25-44                         25-44                          
  Marital status                                                                              0.07
    Single                       68                     26.5   84                      32.7   
    Married                      159                    61.8   156                     60.7   
    Widowed/Divorced             30                     11.7   17                      6.6    
  Education                                                                                   0.068
    No formal education          10                     3.9    8                       3.1    
    Primary school               67                     26.1   52                      20.2   
    Secondary school             78                     30.3   65                      25.3   
    Higher education             102                    39.7   132                     51.4   
  Religion                                                                                    0.689
    Buddhism                     248                    96.5   247                     96.1   
    Islam                        7                      2.7    6                       2.3    
    Christianity                 2                      0.8    4                       1.6    
  Residence                                                                                   1
    North                        1                      0.4    1                       0.4    
    Northeast                    11                     4.3    11                      4.3    
    Central                      176                    68.5   176                     68.5   
    East                         16                     6.2    16                      6.2    
    West                         48                     18.7   48                      18.7   
    South                        5                      1.9    5                       1.9    
  Occupation                                                                                  0.668
    Office employee              92                     35.8   87                      33.8   
    Entrepreneur                 77                     30     85                      33.1   
    Government officer           73                     28.4   75                      29.2   
    Agriculture                  15                     5.8    10                      3.9    
  Monthly family income (baht)                                                                0.066
    \< 10,000                    38                     14.8   34                      13.2   
    10,000-15,000                52                     20.2   48                      18.7   
    15,001-30,000                138                    53.7   124                     48.2   
    \>30,000                     29                     11.3   51                      19.9   
  Mean(SD)                       22,740.08 (9,311.92)          24,174.32 (13,541.38)          
  Min-Max                        7,000-70,000                  7,800-95,000                   

chi-square test

BC and Risk Factors {#sec2-7}
-------------------

Using a univariate analysis, we found that risk factors of developing BC among TPW were family history of BC, history of benign breast tumor, younger age at menarche, parity, miscarriage, OC use, passive smoking, multivitamin use and BMI (p\<0.05) as shown in [Table 2](#T2){ref-type="table"}. Using a multiple unconditional logistic regression analysis, OC use showed the association with BC occurrence after controlling for possible confounding factors (family history of BC, history of benign breast tumor, younger age at menarche, parity, miscarriage, BMI, passive smoking, and multivitamin use). Risk of developing BC with OC use was 3.39 and times (OR~adj~= 3.39, 95%CI=1.99-5.75), When considering the duration of OC use, the more exposed, the more being BC (OR~adj~ 6-10 yrs=3.91, 95%CI = 1.99-7.64, OR~adj~ \>10 yrs=4.23, 95%CI = 2.05-8.71) as shown in [Table 3](#T3){ref-type="table"}.

###### 

Crude Analysis of Characteristics associated with BC among TPW

  Characteristics                  Cases No.   \%     Controls No.   \%     ORc    95%CI        p-value^[a](#t2f1){ref-type="table-fn"}^
  -------------------------------- ----------- ------ -------------- ------ ------ ------------ ----------------------------------------------
  Family history of BC                                                                          
    No                             211         82.1   249            96.9   1.00                
    Yes                            46          17.9   8              3.1    6.79   3.13-14.69   **\< 0.001[\*](#t2f2){ref-type="table-fn"}**
  History of benign breast tumor                                                                
    No                             209         81.3   235            91.3   1.00                
    Yes                            48          18.7   22             8.6    2.45   1.43-4.20    **0.001[\*](#t2f2){ref-type="table-fn"}**
  Age at menarche (yrs)                                                                         
    ≥14                            83          32.3   140            54.5   1.00                
    \<14                           174         67.7   117            45.5   2.51   1.75-3.59    **\< 0.001[\*](#t2f2){ref-type="table-fn"}**
  Parity                                                                                        
    No                             193         75.1   172            66.9   1.00                
    Yes                            64          24.9   85             33.1   0.67   0.45-0.99    **0.041[\*](#t2f2){ref-type="table-fn"}**
  Miscarriage                                                                                   
    No                             186         72.4   214            83.3   1.00                
    Yes                            71          27.6   43             16.7   1.90   1.21-2.98    **0.003[\*](#t2f2){ref-type="table-fn"}**
  OC use                                                                                        
    No                             90          35     162            63.0   1.00                
    Yes                            167         65     95             37.0   3.16   2.21-4.54    **\< 0.001[\*](#t2f2){ref-type="table-fn"}**
  Duration of OC use (yrs)                                                                      
    0                              90          35     162            63.0   1.00                
    1-5                            42          16.3   44             17.1   1.72   1.01-2.90    **0.031[\*](#t2f2){ref-type="table-fn"}**
    6-10                           70          27.2   30             11.7   4.2    2.48-7.17    **\< 0.001[\*](#t2f2){ref-type="table-fn"}**
    \>10                           55          21.5   21             8.2    4.71   2.59-8.72    **\< 0.001[\*](#t2f2){ref-type="table-fn"}**
  Active smoking                                                                                
    No                             248         96.5   251            97.7   1.00                
    Yes                            9           3.5    6              2.3    1.52   0.53-4.33    0.432
  Passive smoking                                                                               
    No                             153         59.5   198            77.1   1.00                
    Yes                            104         40.5   59             22.9   2.28   1.53-3.41    **\< 0.001[\*](#t2f2){ref-type="table-fn"}**
  Alcohol consumption                                                                           
    No                             251         97.7   252            98.1   1.00                
    Yes                            6           2.3    5              1.9    1.20   0.32-4.61    0.761
  Multivitamin use                                                                              
    No                             227         88.3   168            65.4   1                   
    Yes                            30          11.7   89             34.6   0.25   0.15-0.40    **\< 0.001[\*](#t2f2){ref-type="table-fn"}**
  Body mass index (kg/m^2^)                                                                     
    18.5-22.9                      89          34.7   122            47.4   1.00                
    23.0-24.9                      44          17.1   54             21.0   1.12   0.67-1.86    0.629
    25.0-29.9                      88          34.2   41             16.0   2.94   1.81-4.79    **\< 0.001[\*](#t2f2){ref-type="table-fn"}**
    ≥30.0                          26          10.1   10             3.9    3.56   1.55-8.38    **\< 0.001[\*](#t2f2){ref-type="table-fn"}**
    \<18.5                         10          3.9    30             11.7   0.46   0.20-1.05    0.056

chi-square test, ORc= crude odds ratio, CI= confidence interval;

significant at p-value \<0.05.

###### 

Multivariable Logistic Regression Analysis of OC use associated with BC among TPW

  Variables                  OR~c~   95%CI       OR~adj~   95%CI       p-value
  -------------------------- ------- ----------- --------- ----------- ---------------------------------------------
  OC use                                                               
    No                       1                   1                     
    Yes                      3.16    2.21-4.54   3.39      1.99-5.75   **\<0.001[\*](#t3f1){ref-type="table-fn"}**
  Duration of OC use (yrs)                                             
    0                        1                   1                     
    1-5                      1.72    1.01-2.90   1.72      0.90-3.25   0.099
    6-10                     4.2     2.48-7.17   3.91      1.99-7.64   **\<0.001[\*](#t3f1){ref-type="table-fn"}**
    \>10                     4.71    2.59-8.72   4.23      2.05-8.71   **\<0.001[\*](#t3f1){ref-type="table-fn"}**

OR~c~, crude OR; OR~adj~, adjusted OR for family history of BC; history of benign breast tumor, age at menarche, parity, miscarriage, passive smoking, multivitamin use and BMI;

significant at p-value \<0.05

BC Patients' Characteristics {#sec2-8}
----------------------------

Cases were newly patients with BC diagnosed by pathological confirmation and laboratory testing during November 2013-December 2014. Majority of them were 55-64 kg (40.5%) and 150-159 cm (65.7%). Focusing on body size, 60.7% showed obesity and overweight. Location of BC, mostly in both sides (52.2%). Most of study cases were IDC-NOS (91.8%), stage II (45.5%). For OC use group, duration for OC use, mostly 6-10 yr. (41.9%).

Discussion {#sec1-4}
==========

Study participants were the TPW, mostly aged 40-44 years (60%). Socio-demographic characteristics of cases and controls were quite alike. When controlled by health risk behaviors and reproductive factors, found that TPW with OC use was being BC risks. Our findings indicated that women with OC use were about 3 times risk to develop BC. It was consistent with the previous studies (Soroush et al., 2016; Rosenberg et al., 2009; Nyante et al., 2008; Kahlenborn et al., 2006; Newcomer et al., 2003; Hemminki et al., 2002; Grabrick et al., 2000), meanwhile some studies showed the contrary results (Haile et al., 2006; Silvera et al., 2005; Mine et al., 2005; Jernstrom et al., 2005; Tessaro et al., 2001; Van Hoften et al., 2000).

The reason to support the association owing to estrogen hormone in OC pills, therefore it will have a cohesion with specific receptor on cancer cell's surface and then it will send the biochemical signals and activate cell multiplication (Howlader et al., 2016). The association had no evidence in OC use with only progesterone (McNaught et al., 2006). In addition, the present studies revealed the risk of BC had increased according to duration of OC use and it's consistent with some studies (Howlader et al., 2016; Collaborative Group on Hormonal Factors in Breast Cancer, 1996). Therefore, birth control with BC patients should be namely, contraceptive pills with progesterone, depot medroxyprogesterone acetate injection, intrauterine device (IUD) with progesterone, and so on (Kabos and Borges, 2011). In addition, breast self examination is very necessary, so women should be done correctly (Smith et al., 2003). For women ≥ 40 years should be checked up with mammogram annually (Smith et al., 2003; American College of Radiology, 2013). There are a lot of tools for BC risk evaluation, such as the Gail Model, the Claus Model, the Tyree-Cuzick Model and the BRCAPRO model (Santen et al., 2007; Hollingsworth et al., 2004). For Thais, campaign of women aged ≥ 20 years to examine by themselves, they should be aware of advantages and limitations of this technique, support breast feeding after give birth 6 months, reduce alcohol consumption and reduce obesity (National Cancer Control Committee, 2013). Therefore, the surveillance of cancer risk and contraceptive use is the crucial measure to reduce BC risks.

Advantages and limitation of the Study {#sec2-9}
--------------------------------------

There are some advantages of this case-control study. First, the National Cancer Institute is the specialized hospital for cancer patients. Second, they are easily identified, and provide sufficient numbers. Finally, cases are newly BC patients diagnosed and confirmed by pathologists, which lead to the reduction in classification bias. Some limitations of this study should be noted. First, the study was a hospital based case-control study, therefore, the representative of target population couldn't be mentioned. Second, it was very difficult to select the suitable controls. However, we matched cases and controls by age, residence and duration of attending. In summary, it should be the surveillance system of cancer risks and OC use and campaign of cancer prevention such as proper exercise, healthy diet, weight control and basic methods for health lifestyle among risk groups (National Cancer Control Committee, 2013), it will minimize and reduce risks of developing BC.
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